Hal Chapman
Clinical trials sponsored by Hal Chapman, explained in plain language.
-
Green tea compound tested for lung scarring disease
Disease control CompletedThis early-phase study tested a purified green tea extract called EGCG in 50 people with idiopathic pulmonary fibrosis (IPF) who were already taking standard medications. The main goal was to check if EGCG is safe and how it interacts with their usual drugs. Participants took EGC…
Phase: PHASE1 • Sponsor: Hal Chapman • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New imaging technique reveals green tea Extract's effect on scarred lungs
Knowledge-focused CompletedThis study tested whether a new type of PET scan can measure how the supplement EGCG (found in green tea) affects collagen buildup in the lungs of people with idiopathic pulmonary fibrosis (IPF). Twelve participants who were already in a larger EGCG study received an injection of…
Phase: PHASE1 • Sponsor: Hal Chapman • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC